Paper Details
- Home
- Paper Details
Original Abstract of the Article :
BACKGROUND: Patients with decompensated cirrhosis are at risk for hyperfibrinolysis; this is potentially fatal. epsilon-aminocaproic acid has been used to treat patients with hyperfibrinolysis; however, the data about its benefit in the setting of cirrhosis are minimal. AIM: To analyse the efficacy...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1111/j.1365-2036.2006.02730.x
データ提供：米国国立医学図書館（NLM）
Epsilon-Aminocaproic Acid: A Lifeline in the Desert of Cirrhosis
Cirrhosis, a chronic liver disease, often leads to hyperfibrinolysis, a condition characterized by excessive breakdown of blood clots. This can be life-threatening, especially for patients with decompensated cirrhosis. This study investigated the efficacy and safety of epsilon-aminocaproic acid, a medication used to treat hyperfibrinolysis, in patients with cirrhosis.
A Safe and Effective Treatment for Hyperfibrinolysis in Cirrhosis
The study found that epsilon-aminocaproic acid was effective in controlling bleeding episodes in patients with cirrhosis and hyperfibrinolysis. This medication proved to be safe, with only minor side effects reported. This finding offers a valuable treatment option for patients facing this challenging condition.
Managing Hyperfibrinolysis in Cirrhosis
The study provides evidence for the effectiveness and safety of epsilon-aminocaproic acid in treating hyperfibrinolysis in patients with cirrhosis. This medication can help control bleeding episodes, offering a vital lifeline in the face of a serious health challenge. It's like discovering a wellspring of water in the desert, providing much-needed relief and stability.
Dr.Camel's Conclusion
This research highlights the importance of finding safe and effective treatments for complications associated with cirrhosis. By developing new strategies to combat hyperfibrinolysis, like finding a hidden oasis in the desert, we can improve the lives of patients battling this challenging disease.
Date :
- Date Completed 2006-05-03
- Date Revised 2013-11-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.